These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 1747374

  • 1. Development of affinity labeling agents based on nonsteroidal anti-inflammatory drugs: labeling of the nonsteroidal anti-inflammatory drug binding site of 3 alpha-hydroxysteroid dehydrogenase.
    Askonas LJ, Penning TM.
    Biochemistry; 1991 Dec 10; 30(49):11553-60. PubMed ID: 1747374
    [Abstract] [Full Text] [Related]

  • 2. Bromoacetamido analogs of indomethacin and mefenamic acid as affinity-labeling agents and mechanistic probes for prostaglandin H2 synthase.
    Tang MS, Askonas LJ, Penning TM.
    Biochemistry; 1995 Jan 24; 34(3):808-15. PubMed ID: 7827039
    [Abstract] [Full Text] [Related]

  • 3. Affinity-labelling of the anti-inflammatory drug and prostaglandin-binding site of 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol with 17 beta- and 21-bromoacetoxysteroids.
    Penning TM, Carlson KE, Sharp RB.
    Biochem J; 1987 Jul 01; 245(1):269-76. PubMed ID: 3478045
    [Abstract] [Full Text] [Related]

  • 4. The kinetic mechanism catalysed by homogeneous rat liver 3 alpha-hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs.
    Askonas LJ, Ricigliano JW, Penning TM.
    Biochem J; 1991 Sep 15; 278 ( Pt 3)(Pt 3):835-41. PubMed ID: 1898369
    [Abstract] [Full Text] [Related]

  • 5. Affinity labeling of 3 alpha-hydroxysteroid dehydrogenase with 3 alpha-bromoacetoxyandrosterone and 11 alpha-bromoacetoxyprogesterone. Isolation and sequence of active site peptides containing reactive cysteines; sequence confirmation using nucleotide sequence from a cDNA clone.
    Penning TM, Abrams WR, Pawlowski JE.
    J Biol Chem; 1991 May 15; 266(14):8826-34. PubMed ID: 2026597
    [Abstract] [Full Text] [Related]

  • 6. Isolation and partial characterization of a full-length cDNA clone for 3 alpha-hydroxysteroid dehydrogenase: a potential target enzyme for nonsteroidal anti-inflammatory drugs.
    Pawlowski J, Huizinga M, Penning TM.
    Agents Actions; 1991 Sep 15; 34(1-2):289-93. PubMed ID: 1793046
    [Abstract] [Full Text] [Related]

  • 7. Cloning and sequencing of the cDNA for rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase.
    Pawlowski JE, Huizinga M, Penning TM.
    J Biol Chem; 1991 May 15; 266(14):8820-5. PubMed ID: 1840601
    [Abstract] [Full Text] [Related]

  • 8. Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents.
    Gobec S, Brozic P, Rizner TL.
    Bioorg Med Chem Lett; 2005 Dec 01; 15(23):5170-5. PubMed ID: 16183274
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and evaluation of non-steroidal mechanism-based inactivators of 3 alpha-hydroxysteroid dehydrogenase.
    Ricigliano JW, Penning TM.
    Biochem J; 1989 Aug 15; 262(1):139-49. PubMed ID: 2640566
    [Abstract] [Full Text] [Related]

  • 10. Clues to the development of mechanism-based inactivators of 3 alpha-hydroxysteroid dehydrogenase: comparison of steroidal and nonsteroidal Michael acceptors and epoxides.
    Penning TM, Thronton R, Ricigliano JW.
    Steroids; 1991 Aug 15; 56(8):420-7. PubMed ID: 1788860
    [Abstract] [Full Text] [Related]

  • 11. Purification and properties of 3 alpha-hydroxysteroid dehydrogenase from rat brain cytosol. Inhibition by nonsteroidal anti-inflammatory drugs and progestins.
    Penning TM, Sharp RB, Krieger NR.
    J Biol Chem; 1985 Dec 05; 260(28):15266-72. PubMed ID: 2933398
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evidence that enzyme-generated aromatic Michael acceptors covalently modify the nucleotide-binding site of 3 alpha-hydroxysteroid dehydrogenase.
    Ricigliano JW, Penning TM.
    Biochem J; 1990 Aug 01; 269(3):749-55. PubMed ID: 2390066
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of a major NAD(P)-linked oxidoreductase from rat liver cytosol by steroidal and nonsteroidal anti-inflammatory agents and by prostaglandins.
    Penning TM, Talalay P.
    Proc Natl Acad Sci U S A; 1983 Jul 01; 80(14):4504-8. PubMed ID: 6410393
    [Abstract] [Full Text] [Related]

  • 16. Affinity labeling of bovine adrenal 3 beta-hydroxysteroid dehydrogenase/steroid isomerase by 5'-[p-(fluorosulfonyl)benzoyl]adenosine.
    Rutherfurd KJ, Chen SA, Shively JE.
    Biochemistry; 1991 Aug 20; 30(33):8116-23. PubMed ID: 1868087
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of hepatic 17 beta- and 3 alpha-hydroxysteroid dehydrogenases by antiinflammatory drugs and nonsteroidal estrogens.
    Hasebe K, Hara A, Nakayama T, Hayashibara M, Inoue Y, Sawada H.
    Enzyme; 1987 Aug 20; 37(3):109-14. PubMed ID: 3034566
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Purification and properties of a 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs.
    Penning TM, Mukharji I, Barrows S, Talalay P.
    Biochem J; 1984 Sep 15; 222(3):601-11. PubMed ID: 6435601
    [Abstract] [Full Text] [Related]

  • 20. Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2.
    Hata AN, Lybrand TP, Marnett LJ, Breyer RM.
    Mol Pharmacol; 2005 Mar 15; 67(3):640-7. PubMed ID: 15563582
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.